Status epilepticus: risk factors and complications - PubMed (original) (raw)
Review
Status epilepticus: risk factors and complications
N B Fountain. Epilepsia. 2000.
Free article
Abstract
Status epilepticus is common and associated with significant mortality and complications. It affects approximately 50 patients per 100,000 population annually and recurs in >13%. History of epilepsy is the strongest single risk factor for generalized convulsive status epilepticus. More than 15% of patients with epilepsy have at least one episode of status epilepticus and low antiepileptic drug levels are a potentially modifiable risk factor. Other risks include young age, genetic predisposition, and acquired brain insults. Fever is a very common risk in children, as is stroke in adults. Mortality rates are 15% to 20% in adults and 3% to 15% in children. Acute complications result from hyperthermia, pulmonary edema, cardiac arrhythmias, and cardiovascular collapse. Long-term complications include epilepsy (20% to 40%), encephalopathy (6% to 15%), and focal neurologic deficits (9% to 11%). Neuronal injury leading to temporal lobe epilepsy is probably mediated by excess excitation via activation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors and consequent elevated intracellular calcium that causes acute necrosis and delayed apoptotic cell death. Some forms of nonconvulsive status epilepticus may also lead to neuronal injury by this mechanism, but others may not. Based on clinical and experimental observations, complex partial status epilepticus is more likely to result in neuronal injury similar to generalized convulsive status epilepticus. Absence status epilepticus is much less likely to result in neuronal injury, and complications because it may be mediated primarily through excess inhibition. Future research strategies to prevent complications of status epilepticus include the study of new drugs (including NMDA antagonists, new drug delivery systems, and drug combinations) to stop seizure activity and prevent acute and delayed neuronal injury that leads to the development of epilepsy.
Similar articles
- Pathophysiological mechanisms of brain damage from status epilepticus.
Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Wasterlain CG, et al. Epilepsia. 1993;34 Suppl 1:S37-53. doi: 10.1111/j.1528-1157.1993.tb05905.x. Epilepsia. 1993. PMID: 8385002 Review. - Epidemiology and evidence for morbidity of nonconvulsive status epilepticus.
Krumholz A. Krumholz A. J Clin Neurophysiol. 1999 Jul;16(4):314-22; discussion 353. doi: 10.1097/00004691-199907000-00003. J Clin Neurophysiol. 1999. PMID: 10478704 Review. - Status epilepticus in idiopathic generalized epilepsy.
Shorvon S, Walker M. Shorvon S, et al. Epilepsia. 2005;46 Suppl 9:73-9. doi: 10.1111/j.1528-1167.2005.00316.x. Epilepsia. 2005. PMID: 16302878 Review. - [Epileptic seizures in critically ill patients].
Stasiukyniene V, Pilvinis V, Reingardiene D, Janauskaite L. Stasiukyniene V, et al. Medicina (Kaunas). 2009;45(6):501-7. Medicina (Kaunas). 2009. PMID: 19605972 Review. Lithuanian. - Acute Systemic Complications of Convulsive Status Epilepticus-A Systematic Review.
Sutter R, Dittrich T, Semmlack S, Rüegg S, Marsch S, Kaplan PW. Sutter R, et al. Crit Care Med. 2018 Jan;46(1):138-145. doi: 10.1097/CCM.0000000000002843. Crit Care Med. 2018. PMID: 29099419 Review.
Cited by
- Prognostic factors of status epilepticus in children.
Kang DC, Lee YM, Lee J, Kim HD, Coe C. Kang DC, et al. Yonsei Med J. 2005 Feb 28;46(1):27-33. doi: 10.3349/ymj.2005.46.1.27. Yonsei Med J. 2005. PMID: 15744802 Free PMC article. - Prognostic indicators of non-convulsive status epilepticus in intensive care unit.
Aslan-Kara K, Demir T, Satılmış Ü, Peköz T, Bıçakcı Ş, Bozdemir H. Aslan-Kara K, et al. Acta Neurol Belg. 2023 Aug;123(4):1257-1266. doi: 10.1007/s13760-022-01981-6. Epub 2022 Jun 3. Acta Neurol Belg. 2023. PMID: 35657480 - Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus.
Kämppi L, Ritvanen J, Mustonen H, Soinila S. Kämppi L, et al. Epilepsy Res Treat. 2015;2015:591279. doi: 10.1155/2015/591279. Epub 2015 Aug 10. Epilepsy Res Treat. 2015. PMID: 26347816 Free PMC article. - Modified low ratio ketogenic therapy in the treatment of adults with super-refractory status epilepticus.
Kaul N, Nation J, Laing J, Nicolo JP, Deane AM, Udy AA, Kwan P, O'Brien TJ. Kaul N, et al. JPEN J Parenter Enteral Nutr. 2022 Nov;46(8):1819-1827. doi: 10.1002/jpen.2373. Epub 2022 Apr 7. JPEN J Parenter Enteral Nutr. 2022. PMID: 35285036 Free PMC article. - Anticonvulsive evaluation and histopathological survey of thalidomide synthetic analogs on lithium-pilocarpine-induced status epilepticus in rats.
Amanlou A, Eslami F, Shayan M, Mortazavi P, Dehpour AR. Amanlou A, et al. Res Pharm Sci. 2021 Oct 15;16(6):586-595. doi: 10.4103/1735-5362.327505. eCollection 2021 Dec. Res Pharm Sci. 2021. PMID: 34760007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources